Results 11 to 20 of about 163,168 (216)

BTKbase, Bruton Tyrosine Kinase Variant Database in X-Linked Agammaglobulinemia: Looking Back and Ahead. [PDF]

open access: hybridHum Mutat, 2023
BTKbase is an international database for disease-causing variants in Bruton tyrosine kinase (BTK) leading to X-linked agammaglobulinemia (XLA), a rare primary immunodeficiency of antibody production.
Schaafsma GCP   +6 more
europepmc   +4 more sources

Cytomegalovirus Pneumonia in a Patient with X-Linked Agammaglobulinemia: A Case Report [PDF]

open access: yesMedicina, 2022
X-linked agammaglobulinemia (XLA) is a hereditary immune disorder that predisposes patients to frequent and severe bacterial infections caused by encapsulated bacteria (such as Streptococcus pneumoniae, Staphylococcus aureus, and Haemophilus influenzae).
Yao-Xian Wong, Shyh-Dar Shyur
doaj   +3 more sources

Novel BTK Mutation in Patient with Late Diagnosis of X-Linked Agammaglobulinemia [PDF]

open access: goldCase Reports in Immunology, 2023
X-linked agammaglobulinemia (XLA) is a genetic disorder with mutation in Bruton’s tyrosine kinase (BTK). Defects in B cell development and immunoglobulin production lead to recurrent infections following loss of maternal IgG at 6 months of age. A 55-year-
Amanpreet Kalkat   +2 more
doaj   +4 more sources

IgA nephropathy in a child with X-linked agammaglobulinemia: a case report [PDF]

open access: yesBMC Pediatrics
Background X-linked agammaglobulinemia (XLA) is a primary immunodeficiency disease caused by mutations in the Bruton tyrosine kinase (BTK) gene. Individuals diagnosed with XLA are at an increased risk of developing autoimmune diseases.
Yuanjin Song   +4 more
doaj   +3 more sources

Astrovirus Encephalitis in Boy with X-linked Agammaglobulinemia [PDF]

open access: diamondEmerging Infectious Diseases, 2010
Encephalitis is a major cause of death worldwide. Although >100 pathogens have been identified as causative agents, the pathogen is not determined for up to 75% of cases.
Phenix-Lan Quan   +15 more
doaj   +6 more sources

X-Linked Agammaglobulinemia [PDF]

open access: yesDefinitions, 2020
X-linked agammaglobulinemia (XLA) is a condition that affects the immune system and occurs almost exclusively in males. People with XLA have very few B cells, which are specialized white blood cells that help protect the body against infection.
Larry W. Moreland
semanticscholar   +4 more sources

Two X‐linked agammaglobulinemia patients develop pneumonia as COVID‐19 manifestation but recover

open access: yesPediatric Allergy and Immunology, 2020
The recent SARS‐CoV‐2 pandemic, which has recently affected Italy since February 21, constitutes a threat to normal subjects, as the coronavirus disease‐19 (COVID‐19) can manifest with a broad spectrum of clinical phenotypes ranging from asymptomatic ...
Ciro Paolillo   +2 more
exaly   +2 more sources

Chronic Diarrhea with Villous Blunting of the Small Intestine Under Capsule Endoscopy in Common Variable Immunodeficiency and X-Linked Agammaglobulinemia: A Case Series. [PDF]

open access: yesJ Asthma Allergy, 2023
Introduction Primary immunodeficiencies (PIDs) are a heterogeneous group of disorders, common variable immunodeficiency disorder (CVID) and X-linked agammaglobulinemia (XLA) are PIDs related to B-cell defect, characterized by reduced levels of ...
Deng F, Wang H, Wang X.
europepmc   +2 more sources

The dilemma of X-linked agammaglobulinemia carriers [PDF]

open access: yesJournal of Allergy and Clinical Immunology: Global
Background: Many patients with X-linked agammaglobulinemia (XLA) nowadays have reached adulthood, as well as their sisters, possibly carriers of a deleterious Bruton tyrosine kinase variant. Studies on motherhood outcomes in families with XLA are lacking.
Federica Pulvirenti, MD, PhD   +19 more
doaj   +2 more sources

Comprehensive newborn screening for severe combined immunodeficiency, X-linked agammaglobulinemia, and spinal muscular atrophy: the Chinese experience. [PDF]

open access: yesWorld J Pediatr
Newborn screening (NBS) for severe combined immunodeficiency (SCID), X-linked agammaglobulinemia (XLA), and spinal muscular atrophy (SMA) enables early diagnosis and intervention, significantly improving patient outcomes. Advances in real-time polymerase
Chen C   +8 more
europepmc   +2 more sources

Home - About - Disclaimer - Privacy